Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Shares Outstanding for 11 consecutive years, with $187.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 22.62% year-over-year to $187.7 million, compared with a TTM value of $187.7 million through Dec 2025, up 22.62%, and an annual FY2025 reading of $187.7 million, up 22.62% over the prior year.
  • Shares Outstanding was $187.7 million for Q4 2025 at Wave Life Sciences, up from $160.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $187.7 million in Q4 2025 and bottomed at $49.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $107.6 million, with a median of $98.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding grew 6.62% in 2021, then surged 71.47% in 2022.
  • Year by year, Shares Outstanding stood at $59.8 million in 2021, then soared by 45.26% to $86.9 million in 2022, then skyrocketed by 37.09% to $119.2 million in 2023, then increased by 28.43% to $153.0 million in 2024, then increased by 22.62% to $187.7 million in 2025.
  • Business Quant data shows Shares Outstanding for WVE at $187.7 million in Q4 2025, $160.3 million in Q3 2025, and $155.7 million in Q2 2025.